Modeling binding modes of angiotensin II and pseudopeptide analogues to the AT2 receptor

Journal of Molecular Graphics and Modelling

Volumn 26, Issue 6, 2008, Pages 991-1003

  Sköld, Christian ^a   Nikiforovich, Gregory ^b   Karlén, Anders ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; AT2 receptor; Bioactive conformation; Docking; Homology modeling

Indexed keywords

LIGANDS; MATHEMATICAL MODELS; PIGMENTS; THREE DIMENSIONAL;

EXTRACELLULAR LOOPS; HOMOLOGY MODELINGS; PLAUSIBLE BINDING MODES; PSEUDOPEPTIDES;

PEPTIDES;

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; PSEUDOPEPTIDE; RHODOPSIN;

ARTICLE; BINDING AFFINITY; CONFORMATION; HORMONE RECEPTOR INTERACTION; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE;

ANGIOTENSIN II; ANIMALS; BINDING SITES; FEMALE; LIGANDS; MODELS, CHEMICAL; MODELS, MOLECULAR; MYOMETRIUM; OLIGOPEPTIDES; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, ANGIOTENSIN, TYPE 2; RHODOPSIN; STRUCTURAL HOMOLOGY, PROTEIN; SWINE;

EID: 37349115217     PISSN: 10933263     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmgm.2007.08.005     Document Type: Article

References (57)

1. 2 receptors: regulation, signalling and function. Blood Press. 12 (2003) 70-88
2. De Gasparo M., Catt K.J., Inagami T., Wright J.W., and Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol. Rev. 52 (2000) 415-472
3. Mukoyama M., Nakajima M., Horiuchi M., Sasamura H., Pratt R.E., and Dzau V.J. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J. Biol. Chem. 268 (1993) 24539-24542
4. Kambayashi Y., Bardhan S., Takahashi K., Tsuzuki S., Inui H., Hamakubo T., and Inagami T. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J. Biol. Chem. 268 (1993) 24543-24546
5. Spear K.L., Brown M.S., Reinhard E.J., McMahon E.G., Olins G.M., Palomo M.A., and Patton D.R. Conformational restriction of angiotensin II: cyclic analogues having high potency. J. Med. Chem. 33 (1990) 1935-1940
6. 1 receptor. J. Med. Chem. 45 (2002) 1767-1777
7. Plucinska K., Kataoka T., Yodo M., Cody W.L., He J.X., Humblet C., Lu G.H., Lunney E., Major T.C., Panek R.L., Schelkum P., Skeean R., and Marshall G.R. Multiple binding modes for the receptor-bound conformations of cyclic AII agonists. J. Med. Chem. 36 (1993) 1902-1913
8. Sugg E.E., Dolan C.A., Patchett A.A., Chang R.S.L., Faust K.A., and Lotti V.J. In peptides, chemistry, structure biology. pp. 305-306. In: Rivier J.E., and Marshall G.R. (Eds). Proceedings of the 11th American Peptide Symposium. ESCOM, Leiden (1990)
9. Samanen J.M., Peishoff C.E., Keenan R.M., and Weinstock J. Refinement of a molecular model of angiotensin II (AII) employed in the discovery of potent nonpeptide antagonists. Bioorg. Med. Chem. Lett. 3 (1993) 909-914
10. Nikiforovich G.V., Kao J.L.F., Plucinska K., Zhang W.J., and Marshall G.R. Conformational analysis of two cyclic analogs of angiotensin: implications for the biologically active conformation. Biochemistry 33 (1994) 3591-3598
11. Schmidt B., Lindman S., Tong W., Lindeberg G., Gogoll A., Lai Z., Thornwall M., Synnergren B., Nilsson A., Welch C.J., Sohtell M., Westerlund C., Nyberg F., Karlén A., and Hallberg A. Design, synthesis, and biological activities of four angiotensin II receptor ligands with γ-turn mimetics replacing amino acid residues 3-5. J. Med. Chem. 40 (1997) 903-919
12. Printz M.P., Némethy G., and Bleich H. Proposed models for angiotensin II in aqueous solution and conclusions about receptor topography. Nat. New Biol. 237 (1972) 135-140
13. Lindman S., Lindeberg G., Nyberg F., Karlén A., and Hallberg A. Comparison of three γ-turn mimetic scaffolds incorporated into angiotensin II. Bioorg. Med. Chem. 8 (2000) 2375-2383
14. Nikiforovich G.V., and Marshall G.R. Three-dimensional recognition requirements for angiotensin agonists: a novel solution for an old problem. Biochem. Biophys. Res. Commun. 195 (1993) 222-228
15. 1) receptor using the methionine proximity assay. J. Biol. Chem. 280 (2005) 27121-27129
16. 2, parallel to the transmembrane domains and in an extended form. Can. J. Physiol. Pharmacol. 80 (2002) 418-425
17. 2 selective angiotensin II analogues encompassing tyrosine functionalized 5,5-bicyclic thiazabicycloalkane dipeptide mimetics. J. Med. Chem. 47 (2004) 6009-6019
18. 2 receptor affinity. J. Med. Chem. 48 (2005) 6620-6631
19. 2 receptors. J. Med. Chem. 49 (2006) 6133-6137
20. 2 receptor ligand with a γ-turn-like mimetic replacing the amino acid residues 4-5 of angiotensin II. J. Med. Chem. 47 (2004) 859-870
21. 2 receptor ligands encompassing a γ-turn mimetic replacing the amino acid residues 4-5 of angiotensin II act as agonists. J. Med. Chem. 48 (2005) 4009-4024
22. 2 receptor binding properties of angiotensin II analogues. J. Pept. Res. 64 (2004) 194-201
23. Miura S.-I., and Karnik S.S. Angiotensin II type 1 and type 2 receptors bind angiotensin II through different types of epitope recognition. J. Hypertens. 17 (1999) 397-404
24. 2 in ligand binding. Biochem. Biophys. Res. Commun. 263 (1999) 816-819
25. Heerding J.N., Yee D.K., Jacobs S.L., and Fluharty S.J. Mutational analysis of the angiotensin II type 2 receptor: contribution of conserved extracellular amino acids. Regul. Pept. 72 (1997) 97-103
26. 2 receptor in ligand-receptor interaction. Regul. Pept. 73 (1998) 51-58
27. 215) attenuates ligand binding in the angiotensin II type 2 receptor. Mol. Brain Res. 51 (1997) 238-241
28. 2 in ligand-receptor interaction. Biochem. Biophys. Res. Commun. 257 (1999) 704-707
29. 2 receptor in high-affinity binding to different peptide ligands. Peptides 22 (2001) 2145-2149
30. Heerding J.N., Yee D.K., Krichavsky M.Z., and Fluharty S.J. Mutational analysis of the angiotensin type 2 receptor: contribution of conserved amino acids in the region of the sixth transmembrane domain. Regul. Pept. 74 (1998) 113-119
31. Rihakova L., Deraet M., Auger-Messier M., Perodin J., Boucard Antony A., Guillemette G., Leduc R., Lavigne P., and Escher E. Methionine proximity assay, a novel method for exploring peptide ligand-receptor interaction. J. Recept. Signal Transduct. Res. 22 (2002) 297-313
32. 2 receptor with photolabile angiotensin analogs. J. Biol. Chem. 272 (1997) 8653-8659
33. Gether U. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr. Rev. 21 (2000) 90-113
34. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., Le Trong I., Teller D.C., Okada T., Stenkamp R.E., Yamamoto M., and Miyano M. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289 (2000) 739-745
35. 1 receptor and the ligand-binding site. J. Mol. Model. 12 (2006) 325-337
36. Nikiforovich G.V., and Marshall G.R. 3D model for TM region of the AT-1 receptor in complex with angiotensin II independently validated by site-directed mutagenesis data. Biochem. Biophys. Res. Commun. 286 (2001) 1204-1211
37. Nikiforovich G.V., and Marshall G.R. Three-dimensional model for meta-II rhodopsin, an activated G-protein-coupled receptor. Biochemistry 42 (2003) 9110-9120
38. Nikiforovich G.V., and Marshall G.R. Modeling flexible loops in the dark-adapted and activated states of rhodopsin, a prototypical G-protein-coupled receptor. Biophys. J. 89 (2005) 3780-3789
39. Dunfield L.G., Burgess A.W., and Scheraga H.A. Energy parameters in polypeptides. 8. Empirical potential energy algorithm for the conformational analysis of large molecules. J. Phys. Chem. 82 (1978) 2609-2616
40. Nemethy G., Pottle M.S., and Scheraga H.A. Energy parameters in polypeptides. 9. Updating of geometrical parameters, nonbonded interactions, and hydrogen bond interactions for the naturally occurring amino acids. J. Phys. Chem. 87 (1983) 1883-1887
41. http://ca.expasy.org/tools.
42. Nikiforovich G.V., Hruby V.J., Prakash O., and Gehrig C.A. Topographical requirements for d-selective opioid peptides. Biopolymers 31 (1991) 941-955
43. Nikiforovich G.V. Computational molecular modeling in peptide drug design. Int. J. Pept. Protein Res. 44 (1994) 513-531
44. 2 receptor affinity. Bioorg. Med. Chem. 11 (2003) 2947-2954
45. MacroModel, version 9.1 (2005), Schrödinger, LLC, New York, NY
46. Kaminski G.A., Friesner R.A., Tirado-Rives J., and Jorgensen W.L. Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides. J. Phys. Chem. B 105 (2001) 6474-6487
47. Ponder J.W., and Richards F.M. An efficient Newton-like method for molecular mechanics energy minimization of large molecules. J. Comput. Chem. 8 (1987) 1016-1024
48. Saunders M., Houk K.N., Wu Y.D., Still W.C., Lipton M., Chang G., and Guida W.C. Conformations of cycloheptadecane: a comparison of methods for conformational searching. J. Am. Chem. Soc. 112 (1990) 1419-1427
49. Chang G., Guida W.C., and Still W.C. An internal-coordinate Monte Carlo method for searching conformational space. J. Am. Chem. Soc. 111 (1989) 4379-4386
50. Still W.C., Tempczyk A., Hawley R.C., and Hendrickson T. Semianalytical treatment of solvation for molecular mechanics and dynamics. J. Am. Chem. Soc. 112 (1990) 6127-6129
51. Lindman S., Lindeberg G., Gogoll A., Nyberg F., Karlen A., and Hallberg A. Synthesis, receptor binding affinities and conformational properties of cyclic methylenedithioether analogs of angiotensin II. Bioorg. Med. Chem. 9 (2001) 763-772
52. SYBYL 7.1, Tripos Inc., St. Louis, MO, USA.
53. Heerding J.N., Hines J., Fluharty S.J., and Yee D.K. Identification and function of disulfide bridges in extracellular domains of angiotensin II type 2 receptor. Biochemistry 40 (2001) 8369-8377
54. 2 angiotensin II receptor from cysteine-disulfide bond exchange. FEBS Lett. 484 (2000) 133-138
55. Miura S.-i., Karnik S.S., and Saku K. Constitutively active homo-oligomeric angiotensin II type 2 receptor induces cell signaling independent of receptor conformation and ligand stimulation. J. Biol. Chem. 280 (2005) 18237-18244
56. Kobilka B.K., and Deupi X. Conformational complexity of G-protein-coupled receptors. Trends Pharmacol. Sci. 28 (2007) 397-406
57. 1). J. Biol. Chem. 270 (1995) 14024-14030